Zobrazeno 1 - 10
of 252
pro vyhledávání: '"de Heer I"'
Autor:
Ghisai SA; Department of Neurology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands., van Hijfte L; Department of Neurology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands.; Department of Tumour Immunology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands., Vallentgoed WR; Department of Neurology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands., Tesileanu CMS; Department of Neurosurgery, Yale School of Medicine, New Haven, CT, USA., de Heer I; Department of Neurology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands., Kros JM; Department of Pathology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands., Sanson M; ICM Institute for Brain and Spinal Cords, Sorbonne University, Paris, France., Gorlia T; EORTC Headquarters, Brussels, Belgium., Wick W; Neurology Department, University Clinic Heidelberg, Heidelberg University & German Center, Heidelberg, Germany., Vogelbaum MA; Neuro-Oncology Department, Moffitt Cancer Center, Tampa, FL, USA., Brandes AA; Nervous System Medical Oncology Department, IRCCS Istituto delle Scienze Neurologiche di Bologna, Bologna, Italy., Franceschi E; Nervous System Medical Oncology Department, IRCCS Istituto delle Scienze Neurologiche di Bologna, Bologna, Italy., Clement PM; Department of Oncology, Leuven Cancer Institute, KU Leuven, Leuven, Belgium., Nowak AK; Medical School, The University of Western Australia, Crawley, WA, Australia., Golfinopoulos V; EORTC Headquarters, Brussels, Belgium., van den Bent MJ; Department of Neurology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands., French PJ; Department of Neurology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands. p.french@erasmusmc.nl., Hoogstrate Y; Department of Neurology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands.
Publikováno v:
Acta neuropathologica [Acta Neuropathol] 2024 Oct 09; Vol. 148 (1), pp. 50. Date of Electronic Publication: 2024 Oct 09.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Vallentgoed, W., van Dijk, E., van den Bent, M. J., Draaisma, K., van Eijk, P., van Garderen, K., de Heer, I, Hoogstrate, Y., Kouwenhoven, M., Kros, J. M., de Leng, W., van Nee, M., Niers, A., Robe, P., Smits, M., Westerman, B., van de Wiel, M., Ylstra, B., Wesseling, P., French, P. J.
Publikováno v:
Vallentgoed, W, van Dijk, E, van den Bent, M J, Draaisma, K, van Eijk, P, van Garderen, K, de Heer, I, Hoogstrate, Y, Kouwenhoven, M, Kros, J M, de Leng, W, van Nee, M, Niers, A, Robe, P, Smits, M, Westerman, B, van de Wiel, M, Ylstra, B, Wesseling, P & French, P J 2022, ' Disconcordance between different molecular methods to assess homozygous deletion of the CDKN2A/B locus in IDH-mutant astrocytomas ', Neuro-Oncology, vol. 24 . https://doi.org/10.1093/neuonc/noac174.123
Neuro-Oncology, 24. Oxford University Press
Neuro-Oncology, 24. Oxford University Press
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::2a2a0f16dd58a2cd23271ae502fa3e5b
https://research.vumc.nl/en/publications/5fbaf8fa-f9e6-436d-baa5-b002e279aebe
https://research.vumc.nl/en/publications/5fbaf8fa-f9e6-436d-baa5-b002e279aebe
Autor:
Vallentgoed, W. R., Hoogstrate, Y., van Dijk, E., van Garderen, K., Niers, A., van den Bent, M. J., Draaisma, K., van Eijk, P., de Heer, I, Kouwenhoven, M., Kros, J. M., de Leng, W., van Nee, M., Robe, P., Smits, M., Tesileanu, M., Westerman, B., van de Wiel, M., Ylstra, B., Wesseling, P., French, P. J.
Publikováno v:
Vallentgoed, W R, Hoogstrate, Y, van Dijk, E, van Garderen, K, Niers, A, van den Bent, M J, Draaisma, K, van Eijk, P, de Heer, I, Kouwenhoven, M, Kros, J M, de Leng, W, van Nee, M, Robe, P, Smits, M, Tesileanu, M, Westerman, B, van de Wiel, M, Ylstra, B, Wesseling, P & French, P J 2022, ' INTEGRATIVE MOLECULAR ANALYSIS OF MATCHED PRIMARY AND RECURRENT IDH-MUTANT ASTROCYTOMA; AN UPDATE FROM THE GLASS-NL CONSORTIUM ', Neuro-Oncology, vol. 24 . https://doi.org/10.1093/neuonc/noac174.055
Neuro-Oncology, 24. Oxford University Press
Neuro-Oncology, 24. Oxford University Press
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::93ece8053ebe3a3be8559b701e222fba
https://research.vumc.nl/en/publications/5734517e-0903-45d2-9b56-9b503fcba3a8
https://research.vumc.nl/en/publications/5734517e-0903-45d2-9b56-9b503fcba3a8
Autor:
van Garderen KA; Department of Radiology & Nuclear Medicine, Erasmus MC, Rotterdam, The Netherlands.; Brain Tumor Center, Erasmus MC Cancer Institute, Rotterdam, The Netherlands.; Medical Delta, Delft, The Netherlands., Vallentgoed WR; Brain Tumor Center, Erasmus MC Cancer Institute, Rotterdam, The Netherlands.; Department of Neurology, Erasmus MC, Rotterdam, The Netherlands., Lavrova A; Department of Radiology & Nuclear Medicine, Erasmus MC, Rotterdam, The Netherlands., Niers JM; Department of Neurology, Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam, The Netherlands.; Cancer Center Amsterdam, Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam, The Netherlands., de Leng WWJ; Department of Pathology, UMC Utrecht, Utrecht, The Netherlands., Hoogstrate Y; Brain Tumor Center, Erasmus MC Cancer Institute, Rotterdam, The Netherlands.; Department of Neurology, Erasmus MC, Rotterdam, The Netherlands., de Heer I; Brain Tumor Center, Erasmus MC Cancer Institute, Rotterdam, The Netherlands.; Department of Neurology, Erasmus MC, Rotterdam, The Netherlands., Ylstra B; Cancer Center Amsterdam, Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam, The Netherlands.; Department of Pathology, Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam, The Netherlands., van Dijk E; Cancer Center Amsterdam, Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam, The Netherlands.; Department of Pathology, Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam, The Netherlands., Klein S; Department of Radiology & Nuclear Medicine, Erasmus MC, Rotterdam, The Netherlands., Draaisma K; Department of Neurosurgery, UMC Utrecht, The Netherlands., Robe PAJT; Department of Neurosurgery, UMC Utrecht, The Netherlands., Verhaak RGW; Jackson Laboratory for Genomic Medicine, Farmington, CT, USA.; Department of Neurosurgery, Amsterdam UMC, Amsterdam, The Netherlands., Westerman BA; Department of Neurosurgery, Amsterdam UMC, Amsterdam, The Netherlands., French PJ; Brain Tumor Center, Erasmus MC Cancer Institute, Rotterdam, The Netherlands.; Department of Neurology, Erasmus MC, Rotterdam, The Netherlands., van den Bent MJ; Brain Tumor Center, Erasmus MC Cancer Institute, Rotterdam, The Netherlands.; Department of Neurology, Erasmus MC, Rotterdam, The Netherlands., Kouwenhoven MCM; Department of Neurology, Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam, The Netherlands.; Cancer Center Amsterdam, Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam, The Netherlands., Kros JM; Department of Pathology, Erasmus MC, Rotterdam, The Netherlands., Wesseling P; Department of Pathology, Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam, The Netherlands.; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands., Smits M; Department of Radiology & Nuclear Medicine, Erasmus MC, Rotterdam, The Netherlands.; Brain Tumor Center, Erasmus MC Cancer Institute, Rotterdam, The Netherlands.; Medical Delta, Delft, The Netherlands.
Publikováno v:
Neuro-oncology advances [Neurooncol Adv] 2023 Nov 09; Vol. 5 (1), pp. vdad149. Date of Electronic Publication: 2023 Nov 09 (Print Publication: 2023).
Autor:
Hoogstrate Y; Department of Neurology, Erasmus Medical Center, 3015GD Rotterdam, the Netherlands. Electronic address: y.hoogstrate@erasmusmc.nl., Draaisma K; Department of Neurosurgery, UMC Utrecht, 3584CX Utrecht, the Netherlands., Ghisai SA; Department of Neurology, Erasmus Medical Center, 3015GD Rotterdam, the Netherlands., van Hijfte L; Department of Neurology, Erasmus Medical Center, 3015GD Rotterdam, the Netherlands; Laboratory of Tumor Immunology, Department of Medical Oncology, Erasmus Medical Center, 3015GD Rotterdam, the Netherlands., Barin N; Department of Neurology, Erasmus Medical Center, 3015GD Rotterdam, the Netherlands; Department of Precision and Microsystems Engineering, Delft University of Technology, 2628CD Delft, the Netherlands., de Heer I; Department of Neurology, Erasmus Medical Center, 3015GD Rotterdam, the Netherlands., Coppieters W; Genomics Platform, GIGA Institute, Université de Liège, 4000 Liège, Belgium., van den Bosch TPP; Department of Pathology, Erasmus Medical Center, 3015GD Rotterdam, the Netherlands., Bolleboom A; Deparment of Neuroscience, Erasmus Medical Center, 3015GD Rotterdam, the Netherlands; Department of Neurosurgery, Erasmus Medical Center, 3015GD Rotterdam, the Netherlands., Gao Z; Deparment of Neuroscience, Erasmus Medical Center, 3015GD Rotterdam, the Netherlands., Vincent AJPE; Department of Neurosurgery, Erasmus Medical Center, 3015GD Rotterdam, the Netherlands., Karim L; Genomics Platform, GIGA Institute, Université de Liège, 4000 Liège, Belgium., Deckers M; Genomics Platform, GIGA Institute, Université de Liège, 4000 Liège, Belgium., Taphoorn MJB; Department of Neurology, Haaglanden Medical Center, 2512VA The Hague, the Netherlands; Department of Neurology, Leiden University Medical Center, 2333ZA Leiden, the Netherlands., Kerkhof M; Department of Neurology, Haaglanden Medical Center, 2512VA The Hague, the Netherlands., Weyerbrock A; Department of Neurosurgery, Medical Center - University of Freiburg, 79106 Freiburg, Germany; Faculty of Medicine, University of Freiburg, 79085 Freiburg, Germany., Sanson M; Sorbonne Université, Inserm, CNRS, UMR S 1127, Institut du Cerveau et de la Moelle épinière, ICM, AP-HP, Hôpitaux Universitaires La Pitié Salpêtrière - Charles Foix, Service de Neurologie 2-Mazarin, Paris, France., Hoeben A; Department of Internal Medicine, Division of Medical Oncology, GROW, Maastricht University Medical Center, 6229ER Maastricht, the Netherlands., Lukacova S; Department of Oncology, Aarhus University Hospital, 8200 Aarhus, Denmark., Lombardi G; Department of Oncology, Oncology 1, Veneto Institute of Oncology IOV-IRCCS, 35128 Padua, Italy., Leenstra S; Department of Neurosurgery, Erasmus Medical Center, 3015GD Rotterdam, the Netherlands., Hanse M; Department of Neurology, Catharina Hospital, 5623EJ Eindhoven, the Netherlands., Fleischeuer REM; Department of Pathology, Elisabeth-TweeSteden Hospital, 5042AD Tilburg, the Netherlands., Watts C; Institute of Cancer and Genomic Sciences, College of Medical and Dental Sciences, University of Birmingham, B15 2SY Birmingham, UK., Angelopoulos N; Systems Immunity Research Institute, Medical School, Cardiff University, CF14 4XN Cardiff, UK., Gorlia T; EORTC Headquarters, 1200 Brussels, Belgium., Golfinopoulos V; EORTC Headquarters, 1200 Brussels, Belgium., Bours V; Université de Liège, Department of Human Genetics, 4000 Liège, Belgium., van den Bent MJ; Department of Neurology, Erasmus Medical Center, 3015GD Rotterdam, the Netherlands., Robe PA; Department of Neurosurgery, UMC Utrecht, 3584CX Utrecht, the Netherlands; Université de Liège, Department of Human Genetics, 4000 Liège, Belgium., French PJ; Department of Neurology, Erasmus Medical Center, 3015GD Rotterdam, the Netherlands. Electronic address: p.french@erasmusmc.nl.
Publikováno v:
Cancer cell [Cancer Cell] 2023 Apr 10; Vol. 41 (4), pp. 678-692.e7. Date of Electronic Publication: 2023 Mar 09.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Barin N; Department of Precision and Microsystems Engineering, Delft University of Technology, Mekelweg 2, Delft, 2628 CD, The Netherlands.; Department of Neurology, Erasmus MC Cancer Institute, University Medical Center, Doctor Molewaterplein 40, Rotterdam, 3015 GD, The Netherlands., Balcioglu HE; Department of Medical Oncology, Erasmus MC Cancer Institute, University Medical Center, Doctor Molewaterplein 40, Rotterdam, 3015 GD, The Netherlands., de Heer I; Department of Neurology, Erasmus MC Cancer Institute, University Medical Center, Doctor Molewaterplein 40, Rotterdam, 3015 GD, The Netherlands., de Wit M; Department of Neurology, Erasmus MC Cancer Institute, University Medical Center, Doctor Molewaterplein 40, Rotterdam, 3015 GD, The Netherlands., Lamfers MLM; Department of Neurosurgery, Erasmus MC Cancer Institute, University Medical Center, Doctor Molewaterplein 40, Rotterdam, 3015 GD, The Netherlands., van Royen ME; Department of Pathology, Erasmus MC Cancer Institute, University Medical Center, Doctor Molewaterplein 40, Rotterdam, 3015 GD, The Netherlands., French PJ; Department of Neurology, Erasmus MC Cancer Institute, University Medical Center, Doctor Molewaterplein 40, Rotterdam, 3015 GD, The Netherlands., Accardo A; Department of Precision and Microsystems Engineering, Delft University of Technology, Mekelweg 2, Delft, 2628 CD, The Netherlands.
Publikováno v:
Small (Weinheim an der Bergstrasse, Germany) [Small] 2022 Dec; Vol. 18 (49), pp. e2204485. Date of Electronic Publication: 2022 Oct 07.
Autor:
Darlene Mercieca, Gao Y, Bart Valkenburg, Peter A. E. Sillevis Smitt, de Wit M, de Heer I, Pim J. French, van Royen M, Joachim G.J.V. Aerts
Clinical responses to EGFR tyrosine kinase inhibitors are restricted only to tumors harboring specific activating mutations and even then, not all tyrosine kinase inhibitors provide clinical benefit. We here show that the addition of EGFR-TKIs result
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::094ef665d0b3c09dc0655d61b4200054
https://doi.org/10.1101/798314
https://doi.org/10.1101/798314
Autor:
Tesileanu CMS; Neurology Department, Brain Tumor Center, Erasmus MC Cancer Institute, Rotterdam, the Netherlands., Sanson M; Sorbonne Université, Inserm, CNRS, UMR S 1127, Paris Brain Institute - Institut du Cerveau (ICM), AP-HP, Hôpitaux Universitaires La Pitié Salpêtrière - Charles Foix, Service de Neurologie 2-Mazarin, Paris, France., Wick W; Neurology Department, University of Heidelberg, and Clinical Cooperation Unit Neurooncology, German Cancer Consortium (DKTK), German Cancer Research Center (DKFZ), Heidelberg, Germany., Brandes AA; Medical Oncology Department, AUSL-IRCCS Scienze Neurologiche, Bologna, Italy., Clement PM; Oncology Department, KU Leuven and General Medical Oncology Department, UZ Leuven, Leuven Cancer Institute, Leuven, Belgium., Erridge SC; Edinburgh Centre for Neuro-Oncology, Western General Hospital, University of Edinburgh, Edinburgh, United Kingdom., Vogelbaum MA; Neuro-Oncology Department, Moffitt Cancer Center, Tampa, Florida., Nowak AK; Medical School, University of Western Australia, Crawley, Western Australia.; Medical Oncology Department, Sir Charles Gairdner Hospital, Hospital Avenue, Nedlands, Western Australia.; CoOperative Group for NeuroOncology, University of Sydney, New South Wales, Australia., Baurain JF; Medical Oncology Department, King Albert II Cancer Institute, Cliniques universitaires Saint-Luc, Université Catholique de Louvain, Brussels, Belgium., Mason WP; Princess Margaret Cancer Centre, University of Toronto, Toronto, Canada., Wheeler H; Northern Sydney Cancer Centre, University of Sydney, St Leonards, New South Wales, Australia., Chinot OL; Aix-Marseille University, AP-HM, Neuro-Oncology division, Marseille, France., Gill S; Medical Oncology Department, Alfred Hospital, Melbourne, Australia., Griffin M; Clinical Oncology Department, Nottingham University Hospitals NHS Trust, Nottingham, United Kingdom., Rogers L; Radiation Oncology Department, Gammawest Cancer Services, Salt Lake City, Utah., Taal W; Neurology Department, Brain Tumor Center, Erasmus MC Cancer Institute, Rotterdam, the Netherlands., Rudà R; Neuro-Oncology Department, City of Health and Science Hospital and University of Turin, Turin, Italy., Weller M; Neurology Department, Clinical Neuroscience Center, University Hospital and University of Zurich, Zurich, Switzerland., McBain C; Clinical Oncology Department, The Christie NHS FT, Manchester, United Kingdom., van Linde ME; Medical Oncology Department, Brain Tumor Center Amsterdam, Amsterdam UMC, Amsterdam, the Netherlands., Aldape K; Princess Margaret Cancer Centre, University of Toronto, Toronto, Canada., Jenkins RB; Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minnesota., Kros JM; Pathology Department, Erasmus MC Cancer Institute, Rotterdam, the Netherlands., Wesseling P; Pathology Department, Amsterdam University Medical Centers, Amsterdam, the Netherlands.; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands., von Deimling A; Neuropathology Department, Ruprecht-Karls-University, and CCU Neuropathology German Cancer Institute and Consortium, DKFZ, and DKTK, Heidelberg, Germany., Hoogstrate Y; Neurology Department, Brain Tumor Center, Erasmus MC Cancer Institute, Rotterdam, the Netherlands., de Heer I; Neurology Department, Brain Tumor Center, Erasmus MC Cancer Institute, Rotterdam, the Netherlands., Atmodimedjo PN; Pathology Department, Erasmus MC Cancer Institute, Rotterdam, the Netherlands., Dubbink HJ; Pathology Department, Erasmus MC Cancer Institute, Rotterdam, the Netherlands., Brouwer RWW; Center for Biomics, Erasmus MC, Rotterdam, the Netherlands., van IJcken WFJ; Center for Biomics, Erasmus MC, Rotterdam, the Netherlands., Cheung KJ; EORTC HQ, Brussels, Belgium., Golfinopoulos V; EORTC HQ, Brussels, Belgium., Baumert BG; Radiation-Oncology Department (MAASTRO), Maastricht University Medical Center (MUMC) and GROW (School for Oncology), Maastricht, the Netherlands.; Institute of Radiation-Oncology, Cantonal Hospital Graubünden, Chur, Switzerland., Gorlia T; EORTC HQ, Brussels, Belgium., French PJ; Neurology Department, Brain Tumor Center, Erasmus MC Cancer Institute, Rotterdam, the Netherlands., van den Bent MJ; Neurology Department, Brain Tumor Center, Erasmus MC Cancer Institute, Rotterdam, the Netherlands.
Publikováno v:
Clinical cancer research : an official journal of the American Association for Cancer Research [Clin Cancer Res] 2022 Jun 13; Vol. 28 (12), pp. 2527-2535.